Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 512.0K |
Gross Profit | -512.0K |
Operating Expense | 8,168.0K |
Operating I/L | -8,168.0K |
Other Income/Expense | -499.0K |
Interest Income | 0.0K |
Pretax | -8,667.0K |
Income Tax Expense | 26.0K |
Net Income/Loss | -8,693.0K |
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company specializing in diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. The company's Alpha-DaRT technology is used in clinical trials for skin, oral, pancreatic, and breast cancers, as well as in preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.